Angiotech to webcast conference call discussing first quarter 2005 financial results
27 April 2005 - 4:00PM
PR Newswire (US)
Angiotech to webcast conference call discussing first quarter 2005
financial results VANCOUVER, April 27 /PRNewswire-FirstCall/ --
Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP),
will webcast its conference call discussing financial results for
the first quarter ended March 30th, 2005 on Wednesday, May 4th,
2005 at 2:00 PM PST (5:00 PM EST). The webcast will be available to
all interested parties through Angiotech's website
(http://www.angiotech.com/) under Investor Relations or by dialing
toll-free in North America to (800-510-9661) (International callers
please dial (617) 614-3452) and entering Passcode 98019456. To
ensure a timely connection to the webcast it is recommended that
users register approximately 15 minutes before the conference call.
A recording of the call will be available until May 11th, 2005 by
dialing toll-free in North America (888) 286-8010 (International at
(617) 801-6888) and entering Passcode 20027692. A press release
will be issued prior to the conference call. The conference call
will be hosted by William Hunter, President and Chief Executive
Officer, and David Hall, Chief Financial Officer. The webcast will
be available for seven days on the Angiotech website.
Vancouver-based Angiotech Pharmaceuticals, Inc. is a specialty
pharmaceutical company pioneering the combination of pharmaceutical
compounds with medical devices and biomaterials to both create
novel solutions for challenging disease states and advance surgical
outcomes. To find out more about Angiotech Pharmaceuticals, Inc.
(NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), please visit our website at
http://www.angiotech.com/. CONTACTS: Todd Young, Angiotech
Pharmaceuticals (Analysts & Investors) (604) 221-7676 ext 6933
Rui Avelar, Angiotech Pharmaceuticals, Inc. (Analysts) (604)
221-7676 ext 6996 Eric Starkman, Starkman & Associates (Media)
(212) 252-8545 ext 12 DATASOURCE: Angiotech Pharmaceuticals, Inc.
CONTACT: Todd Young, Angiotech Pharmaceuticals (Analysts &
Investors), (604) 221-7676 ext 6933; Rui Avelar, Angiotech
Pharmaceuticals, Inc. (Analysts), (604) 221-7676 ext 6996; Eric
Starkman, Starkman & Associates (Media), (212) 252-8545 ext 12
Copyright
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals - Common Shares (MM) News-Artikel